Please register to continue your trial period!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
MMR deficiency and potential MSI-H status have been recognized as important prognostic biomarkers for patients with pancreatic cancer. Patients with MSI-H status tend to be younger and exhibit unique tumor characteristics.
DNA mismatch repair proteins (MMR with MSI-H) have showed excellent responses in PDAC, which is about 3% of PDAC
see also:
DNA Mismatch Repair (dMMR)
Pancreatic ductal adenocarcinoma (PDAC) / Pancreatic cancer
…